AU2002321767A1 - Tr xidatin agonists and antagonists treatment of metabolic disorders - Google Patents

Tr xidatin agonists and antagonists treatment of metabolic disorders

Info

Publication number
AU2002321767A1
AU2002321767A1 AU2002321767A AU2002321767A AU2002321767A1 AU 2002321767 A1 AU2002321767 A1 AU 2002321767A1 AU 2002321767 A AU2002321767 A AU 2002321767A AU 2002321767 A AU2002321767 A AU 2002321767A AU 2002321767 A1 AU2002321767 A1 AU 2002321767A1
Authority
AU
Australia
Prior art keywords
xidatin
agonists
metabolic disorders
antagonists treatment
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002321767A
Inventor
Kristen Briggs
Deno Dialynas
John Lucas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Publication of AU2002321767A1 publication Critical patent/AU2002321767A1/en
Abandoned legal-status Critical Current

Links

AU2002321767A 2001-08-03 2002-07-31 Tr xidatin agonists and antagonists treatment of metabolic disorders Abandoned AU2002321767A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/310,088 2001-08-03

Publications (1)

Publication Number Publication Date
AU2002321767A1 true AU2002321767A1 (en) 2003-02-24

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002339691A1 (en) Agonists and antagonists of prolixin for the treatment of metabolic disorders
AU2003223579A1 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2002339673A1 (en) Agonists and antagonists of ryzn for the treatment of metabolic disorders
AU2001248971A1 (en) Use of npy y1 receptor agonists in the treatment of pain conditions
AU2002328173A1 (en) Omoxin agonists and antagonists for use in the treatment of metabolic disorders
AU2002321767A1 (en) Tr xidatin agonists and antagonists treatment of metabolic disorders
AU2002363228A1 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
AU2002339680A1 (en) Agonists and antagonists of bromix for the treatment of metabolic disorders
AU2002339682A1 (en) Emergen agonists and antagonists for use in the treatment of metabolic disorders
AU2002339668A1 (en) Treatment of metabolic disorders with xitar agonists and antagonists
AU2002339681A1 (en) Agonists and antagonists of glucomin for the treatment of metabolic disorders
AU2002329001A1 (en) Agonists and antagonists of cylixin for the treatment of metabolic disorders
AU2002313580A1 (en) Xobesin agonists and antagonists for the treatment of metabolic disorders
AU2002321761A1 (en) Agonists and antagonists of disomet for the treatment of metabolic disorders
AU2002321766A1 (en) Agonists and antagonists of obesingen for the treatment of metabolic disorders
AU2002321769A1 (en) Agonists and antagonists of cobesin for the treatment of metabolic disorders
AU2002321770A1 (en) Agonists and antagonists of genceptin for the treatment of metabolic disorders
AU2002324297A1 (en) Agonists and antagonists of moxifin for the treatment of metabolic disorders
AU2002339685A1 (en) Agonists and antagonists of oxifan for the treatment of metabolic disorders
AU2002324300A1 (en) Agonists and antagonists of moceptin for the treatment of metabolic disorders
AU2002339683A1 (en) Agonist and antagonists of redax for the treatment of metabolic disorders
AU2002328096A1 (en) Faxigen agonists and antagonists in the treatment of metabolic disorders
AU2002324296A1 (en) Agonists and antagonists of energen for use in the treatment of metabolic disorders
AU2002321764A1 (en) Genobix agonists and antagonists for use in the treatment of metabolic disorders